-
公开(公告)号:US20220135701A1
公开(公告)日:2022-05-05
申请号:US17500741
申请日:2021-10-13
Applicant: Genentech, Inc.
Inventor: Wei-Ching LIANG , WeiYu Lin , Yan Wu , Minhong Yan
Abstract: The present disclosure provides anti-MerTK antibodies and methods of use thereof. The methods comprise administering an anti-MerTK antibody or an immunoconjugate thereof.
-
公开(公告)号:US11845799B2
公开(公告)日:2023-12-19
申请号:US17119753
申请日:2020-12-11
Applicant: Genentech, Inc.
Inventor: WeiYu Lin , Christoph Spiess , Liping Sun , Yan Wu , Cecilia P. C. Chiu , Walter Christian Darbonne , Michael Andrew Dillon
CPC classification number: C07K16/2824 , C07K16/2809 , A61K2039/507 , C07K2317/565 , C07K2317/567 , C07K2317/92
Abstract: Provided herein are anti-Ly6G6D (lymphocyte antigen 6 complex, locus G61) antibodies and methods of using the same.
-
公开(公告)号:US20240279322A1
公开(公告)日:2024-08-22
申请号:US18420510
申请日:2024-01-23
Applicant: Genentech, Inc.
Inventor: Wei-Ching Liang , Joseph R. Arron , Daryle DePianto , Wendy Green Halpern , WeiYu Lin , Patrick J. Lupardus , Thirumalai Rajan Ramalingam , Dhaya Seshasayee , Tianhe Sun , Tulika Tyagi , Jia Wu , Yan Wu , Jian Ping Yin
IPC: C07K16/22 , A61K39/00 , A61K39/395 , A61P11/00 , C07K16/46
CPC classification number: C07K16/22 , A61P11/00 , C07K16/464 , A61K39/39533 , A61K39/39566 , A61K2039/505 , C07K2317/24 , C07K2317/31 , C07K2317/41 , C07K2317/565 , C07K2317/76 , C07K2317/92
Abstract: The invention provides isoform-selective anti-TGFβ antibodies and methods of using the same. In particular, isoform-selective anti-TGFβ2, anti-TGFβ3, and anti-TGFβ2/3 monoclonal antibodies are provided, e.g., for the treatment of fibrosis and other TGFβ-related disorders.
-
公开(公告)号:US11919948B2
公开(公告)日:2024-03-05
申请号:US17205663
申请日:2021-03-18
Applicant: Genentech, Inc.
Inventor: Wei-Ching Liang , Joseph R. Arron , Daryle Depianto , Wendy Green Halpern , WeiYu Lin , Patrick J. Lupardus , Thirumalai Rajan Ramalingam , Dhaya Seshasayee , Tianhe Sun , Tulika Tyagi , Jia Wu , Yan Wu , Jian Ping Yin
IPC: C07K16/22 , A61K39/00 , A61K39/395 , A61P11/00 , C07K16/46
CPC classification number: C07K16/22 , A61P11/00 , C07K16/464 , A61K39/39533 , A61K39/39566 , A61K2039/505 , C07K2317/24 , C07K2317/31 , C07K2317/41 , C07K2317/565 , C07K2317/76 , C07K2317/92
Abstract: The invention provides isoform-selective anti-TGFβ antibodies and methods of using the same. In particular, isoform-selective anti-TGFβ2, anti-TGFβ3, and anti-TGFβ2/3 monoclonal antibodies are provided, e.g., for the treatment of fibrosis and other TGFβ-related disorders.
-
-
-